체외막 산소화 시장 조사 - 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPHE100001219
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 162
Buy Now

세계 체외 막 산소화 시장은 2021년에 5억 4,673만 달러였으며 2028년에는 6억 7,764만 달러에 이를 것으로 예상됩니다. 이 시장은 2022-2028년 동안 연평균 3.1% 성장할 것으로 예상됩니다.

체외막산소화(extracorporeal membrane oxygenation)는 인공폐를 통한 혈액순환을 위해 사용하는 치료법이다. 이 시스템은 체외에서 심장-폐 우회 경로를 제공하는 데 도움이 됩니다. 이것은 또한 폐 이식이 필요한 환자에게 지원을 제공합니다. 체외 막 산소화 시장의 성장은 심혈관 질환 및 호흡 부전의 유병률 증가와 폐 이식 절차에서 체외 막 산소화의 채택 증가에 기인합니다. 그러나 체외 막 산소화와 관련된 합병증은 시장의 성장을 방해합니다.



전략적 통찰력



체외 막 산소화 시장의 유리한 지역



시장 통찰력

폐 이식 절차에서 체외 막 산소화의 채택 증가는 체외 막 산소화 시장 성장을 주도합니다



폐 이식은 COPD와 같은 말기 폐 질환으로 고통받는 환자를 위한 생명을 구하는 치료 옵션입니다. 특발성 폐섬유증(IPF) 및 낭포성 섬유증은 삶의 질을 향상시킵니다. 체외 막 산소화는 수술 전, 수술 중 및 수술 후 기간과 같은 모든 폐 이식 단계에서 사용되는 다목적 도구입니다. 폐 이식을 받는 환자에게 다리 역할을 합니다. 따라서 생명을 위협하는 폐 질환 환자를 관리하기 위해 폐 이식 중 체외 막 산소화의 채택이 급속히 증가하고 있습니다. SRTR(Scientific Registry of Transplant Recipients)에 따르면 매년 전 세계적으로 약 4,600건의 폐 이식이 수행되며 그 중 55%가 북미에서 수행됩니다. 같은 소식통에 따르면 약 2,759명의 환자가 폐 이식을 받았으며 약 3,243명의 환자가 미국에서 폐 이식 대기자 명단에 추가되었습니다. 1차 이식 기능 장애(PGD)는 폐 이식 후 사망의 주요 원인입니다. 따라서 체외 막 산소화는 폐 이식 후 PGD를 치료하는 데 두 번째로 사용됩니다. NLM(National Library Medicine)에 따르면 2022년 PGD의 전체 발생률은 30%이며, 위험 요인에는 수술 전 기증자 폐 허혈, 장기 획득, 보존 기술, 수술 중 장기 이식 및 재관류가 포함됩니다. 따라서 PGD 환자 치료를 위한 체외막산소화 장비에 대한 수요가 증가하고 있습니다.



Modality-Based Insights



전세계 체외막산소화 시장은 Modality를 기반으로 다음과 같이 세분화됩니다. 정맥동맥 체외막 산소화, 정맥혈 체외막 산소화, 동정맥 체외막 산소화. venoarterial extracorporeal membrane oxygenation 세그먼트는 2021년에 시장에서 가장 큰 점유율을 차지했습니다. 또한 동일한 세그먼트는 예측 기간 동안 시장에서 3.8%의 가장 높은 CAGR을 기록할 것으로 예상됩니다. Venoarterial (VA) 체외 막 산소화는 환자의 심장을 통과하지 않고 회로를 통해 혈액을 밀어 넣어 환자의 심장과 폐를 지원합니다. 이러한 유형의 체외막 산소화는 큰 정맥에서 혈액을 빼내어 큰 동맥으로 되돌려 보내어 심장이 너무 약해서 펌핑할 수 없는 경우에도 산소가 풍부한 혈액이 몸 전체를 순환할 수 있도록 합니다. Veno-arterial 체외 막 산소화(VA-extracorporeal membrane oxygenation)는 지난 10년 동안 널리 적용되었습니다. 다양한 병인의 불응성 심인성 쇼크에서 효과적이고 가치 있는 치료 옵션입니다. 병원 내 심정지의 특정 설정에서 유망한 결과를 보였고 신경학적 결과가 좋은 생존율은 20%에서 40% 사이로 보고되었습니다. /h3>

연령대 기반 통찰력



연령대를 기준으로 전 세계 체외 막 산소화 시장은 성인, 소아 및 신생아로 분류됩니다. 성인 부문은 2021년에 시장에서 가장 큰 점유율을 차지했으며 2022-2028년 동안 3.7%의 CAGR을 기록할 것으로 예상됩니다. 체외 막 산소화는 심부전 또는 호흡 부전으로 고통받는 성인 환자를 돕습니다. 또한, 체외 막 산소화 회로의 최근 기술 발전으로 인해 기술적 문제 및 합병증의 비율이 감소했습니다.



체외 막 산소화 - 시장 세분화



체외 막 산소화 시장은 양식, 응용 프로그램, 연령 그룹 및 지리를 기준으로 세분화됩니다. 양식에 따라 시장은 정맥 동맥 체외 막 산소화, 정맥 체외 막 산소화, 동정맥 체외 막 산소화로 분류됩니다. 응용 프로그램에 따라 체외 막 산소화 시장은 호흡기 및 심장학으로 분기됩니다. 최종 사용자 측면에서 체외 막 산소화 시장은 성인, 소아 및 신생아로 분류됩니다. 지역별로 체외 막 산소화 시장은 북미(미국, 캐나다 및 멕시코), 유럽(영국, 독일, 프랑스, 이탈리아, 스페인 및 기타 유럽), 아시아 태평양(중국, 일본, 인도, 오스트레일리아, 한국 및 기타 아시아 태평양 지역), 중동 및 아프리카(UAE, 사우디아라비아, 아프리카 및 기타 중동 및 아프리카), 중남미(브라질, 아르헨티나 및 기타 국가) 중남미).



제품 출시 및 승인은 기업이 체외 막 산소화 시장 점유율을 지배하기 위해 글로벌 발자국과 제품 포트폴리오를 확장하기 위해 일반적으로 채택하는 전략입니다. 또한 시장 참여자는 고객을 확대하기 위한 파트너십 전략에 초점을 맞추고 있으며, 이를 통해 전 세계에서 브랜드 이름을 유지할 수 있습니다. 이 시장은 시장 참여자들의 새롭고 혁신적인 제품 개발로 인해 향후 몇 년 동안 번창할 것으로 예상됩니다.



회사 프로필



  • Terumo Group

  • Medtronic Plc

  • MicroPort Scientific Corporation

  • LivaNova Plc

  • Nipro Medical Corporation

  • Eurosets SRL

  • Getinge AB< /li>
  • Braile Biomedica

  • Fresenius Medical Care AG & Co KGaA

  • ABIOMED Inc


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the extracorporeal membrane oxygenation market?

The global extracorporeal membrane oxygenation market based on modality is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. In 2021, the venoarterial extracorporeal membrane oxygenation segment accounted for the highest share, moreover the same segment is expected to grow faster at a CAGR of 3.8% in the forecast period.

Who are the major players in market the extracorporeal membrane oxygenation market?

The extracorporeal membrane oxygenation market majorly consists of the players such as Terumo Group, Medtronic Plc. MicroPort Scientific Corporation, LivaNova Plc, Nipro Medical Corporation, Eurosets S.R.L., Getinge AB, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, and ABIOMED Inc.

What are the restraining factors for the extracorporeal membrane oxygenation market across the country?

The complications associated with extracorporeal membrane oxygenation is expected to restrict the market growth during the forecast period

What are the driving factors for the extracorporeal membrane oxygenation market across the country?

Factors such as the rising prevalence of cardiovascular diseases and respiratory failures and further growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures.

What is the extracorporeal membrane oxygenation market?

Extracorporeal membrane oxygenation (ECMO) is a treatment used for the circulation of blood through an artificial lung back into the bloodstream. The system enables to provide heart-lung bypass route outside the body. This also provides support to patients who need a lung transplant. The main purpose of extracorporeal membrane oxygenation is to provide oxygen to the body to heal or rest.

Which region is dominating the extracorporeal membrane oxygenation market?

The global extracorporeal membrane oxygenation market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2021, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 3.9% during the forecast period.

The List of Companies - Extracorporeal Membrane Oxygenation Market

  1. Terumo Group
  2. Medtronic Plc
  3. MicroPort Scientific Corporation
  4. LivaNova Plc
  5. Nipro Medical Corporation
  6. Eurosets S.R.L.
  7. Getinge AB
  8. Braile Biomedica
  9. Fresenius Medical Care AG & Co KGaA
  10. ABIOMED Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports